Interleukin-17 inhibitor, is it safer than tumor necrosis factor inhibitor?

Huang, Jinxian; Zhang, Lijun; Wei, James C-C

Huang, Jinxian; Zhang, Lijun; Wei, James C-C.

Afiliação

Huang J; Division of Rheumatology, Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Zhang L; Division of Rheumatology, Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
Wei JC; Department of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.

Int J Rheum Dis ; 24(7): 865-868, 2021 Jul.

Article em En | MEDLINE | ID: mdl-34241967

Assuntos

Artrite/terapia; Interleucina-17/uso terapêutico; Osteoartrite/terapia; Inibidores do Fator de Necrose Tumoral/uso terapêutico; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoartrite / Artrite / Interleucina-17 / Inibidores do Fator de Necrose Tumoral Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google